HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andrew W Roberts Selected Research

Myeloid Cell Leukemia Sequence 1 Protein

11/2020Targeting MCL-1 in hematologic malignancies: Rationale and progress.
11/2017Promising efficacy and acceptable safety of venetoclax plus bortezomib and dexamethasone in relapsed/refractory MM.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andrew W Roberts Research Topics

Disease

39Neoplasms (Cancer)
01/2022 - 10/2002
25B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
11/2022 - 02/2012
10Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 05/2015
10Multiple Myeloma
12/2021 - 01/2009
9Leukemia
01/2021 - 10/2006
8Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2022 - 04/2008
7Disease Progression
01/2021 - 06/2016
6B-Cell Lymphoma (Lymphoma, B Cell)
01/2022 - 01/2016
6Thrombocytopenia (Thrombopenia)
01/2021 - 10/2006
6Inflammation (Inflammations)
05/2014 - 08/2004
5Opioid-Related Disorders (Opiate Addiction)
01/2022 - 10/2016
5Pain (Aches)
12/2021 - 04/2015
5Lymphadenopathy
11/2019 - 05/2005
5Lymphoma (Lymphomas)
10/2016 - 11/2008
4Substance-Related Disorders (Drug Abuse)
01/2022 - 10/2016
4Residual Neoplasm
01/2021 - 02/2017
4Cancer Pain
12/2020 - 01/2020
4Breast Neoplasms (Breast Cancer)
01/2020 - 01/2019
4Infections
01/2020 - 01/2012
4Rheumatoid Arthritis
01/2016 - 08/2004
4Splenomegaly
04/2015 - 02/2004
4Experimental Arthritis
01/2012 - 08/2004
3Opiate Overdose
01/2021 - 01/2019
3Neutropenia
01/2021 - 03/2005
3Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2021 - 03/2017
3Arthritis (Polyarthritis)
12/2008 - 08/2004
3Thrombocytosis (Thrombocythemia)
03/2007 - 05/2005
2Hematologic Neoplasms (Hematological Malignancy)
01/2021 - 12/2015
2Anemia
01/2021 - 04/2015
2Tumor Lysis Syndrome
10/2018 - 02/2017
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2016 - 03/2010
2Autoimmune Diseases (Autoimmune Disease)
02/2013 - 08/2010
2Graft vs Host Disease (Graft-Versus-Host Disease)
07/2010 - 07/2003
1Hypertension (High Blood Pressure)
01/2022
1Pneumonia (Pneumonitis)
01/2022
1Atrial Fibrillation
01/2022
1Diabetes Complications
01/2022
1Type 2 Diabetes Mellitus (MODY)
01/2022
1Diarrhea
01/2022
1Fever (Fevers)
01/2022
1Sepsis (Septicemia)
01/2022
1Hepatitis C
01/2022
1Hypercholesterolemia
01/2022
1Immune System Diseases (Immune Disorders)
01/2022
1Colorectal Neoplasms (Colorectal Cancer)
01/2021
1COVID-19
01/2021
1Cytopenia
01/2021
1Waldenstrom Macroglobulinemia (Macroglobulinemia)
10/2020
1Philadelphia Chromosome
01/2020
1Chronic Pain
01/2020
1Poisoning
01/2020
1Drug-Related Side Effects and Adverse Reactions
01/2020
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2019

Drug/Important Bio-Agent (IBA)

39venetoclaxIBA
11/2022 - 02/2013
17Proteins (Proteins, Gene)FDA Link
11/2022 - 07/2008
11Opioid Analgesics (Opioids)IBA
12/2021 - 04/2015
7Granulocyte Colony-Stimulating Factor (G-CSF)IBA
12/2008 - 10/2002
6CytokinesIBA
01/2016 - 05/2005
6navitoclaxIBA
01/2016 - 03/2010
5ibrutinibIBA
01/2022 - 01/2018
5Pharmaceutical PreparationsIBA
01/2021 - 03/2005
5Interleukin-6 (Interleukin 6)IBA
01/2012 - 05/2005
4Agammaglobulinaemia Tyrosine KinaseIBA
01/2022 - 10/2020
4zanubrutinibIBA
01/2022 - 12/2019
3Naloxone (Narcan)FDA LinkGeneric
01/2022 - 01/2019
3Prednisolone (Predate)FDA LinkGeneric
12/2021 - 04/2009
3Rituximab (Mabthera)FDA Link
01/2021 - 09/2015
3Bortezomib (Velcade)FDA Link
01/2020 - 04/2008
3ABT-737IBA
03/2010 - 11/2006
2Myeloid Cell Leukemia Sequence 1 ProteinIBA
11/2020 - 11/2017
2Cytarabine (Cytosar-U)FDA LinkGeneric
10/2020 - 05/2017
2Biological ProductsIBA
11/2019 - 08/2006
2S63845IBA
01/2019 - 10/2016
2Immunoglobulin M (IgM)IBA
01/2017 - 04/2002
2Controlled SubstancesIBA
11/2016 - 10/2016
2Thalidomide (Thalomid)FDA Link
12/2014 - 04/2009
2fludarabineIBA
02/2012 - 07/2003
2Hemostatics (Antihemorrhagics)IBA
08/2011 - 10/2006
1DNA (Deoxyribonucleic Acid)IBA
01/2022
1Lenalidomide (CC 5013)FDA Link
12/2021
1Complement System Proteins (Complement)IBA
11/2020
1Immunoglobulins (Immunoglobulin)IBA
01/2020
1Dexamethasone (Maxidex)FDA LinkGeneric
01/2020
1Morphine (MS Contin)FDA LinkGeneric
01/2020
1BenzodiazepinesIBA
01/2020
1Tyrosine Kinase InhibitorsIBA
01/2020
1Chimeric Antigen ReceptorsIBA
01/2020
1blinatumomabIBA
01/2020
1gilteritinibIBA
08/2019
1Circulating Tumor DNAIBA
01/2019
1S55746IBA
01/2019

Therapy/Procedure

33Therapeutics
11/2022 - 10/2006
6Stem Cell Transplantation
12/2021 - 07/2003
6Drug Therapy (Chemotherapy)
10/2020 - 10/2002
1Drug Tapering
01/2022
1Glycemic Control
01/2022
1Physical Therapy Modalities (Physical Therapy Technique)
12/2021
1Minor Surgical Procedures (Minor Surgery)
12/2020
1Pain Management
12/2020
1Palliative Care (Palliative Therapy)
12/2020